Pages that link to "Q35146078"
Jump to navigation
Jump to search
The following pages link to Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. (Q35146078):
Displaying 50 items.
- BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review (Q31002780) (← links)
- Non-invasive metabolic imaging of brain tumours in the era of precision medicine (Q31115540) (← links)
- Actionable molecular biomarkers in primary brain tumors (Q33772355) (← links)
- Pediatric high-grade glioma: biologically and clinically in need of new thinking (Q33777868) (← links)
- Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas (Q34552042) (← links)
- KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas (Q35751428) (← links)
- Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape (Q35754390) (← links)
- Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing. (Q35894536) (← links)
- BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation (Q36197530) (← links)
- Targeted Therapy for MAPK Alterations in Pediatric Gliomas (Q36233325) (← links)
- EGFR blockade prevents glioma escape from BRAFV600E targeted therapy (Q36355848) (← links)
- Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells (Q36421110) (← links)
- Biomarker-based prognostic stratification of young adult glioblastoma (Q36782664) (← links)
- Development and clinical application of an integrative genomic approach to personalized cancer therapy (Q36954557) (← links)
- Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model (Q37689031) (← links)
- Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas (Q37702320) (← links)
- The evolving molecular genetics of low-grade glioma (Q38349169) (← links)
- Review of low-grade gliomas in children--evolving molecular era and therapeutic insights (Q38365733) (← links)
- Toward precision medicine in glioblastoma: the promise and the challenges (Q38454659) (← links)
- Glioblastoma: pathology, molecular mechanisms and markers (Q38460865) (← links)
- BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment (Q38569221) (← links)
- BRAF inhibitors in BRAF-V600 mutated primary neuroepithelial brain tumors. (Q38625131) (← links)
- An update on genomic-guided therapies for pediatric solid tumors. (Q38673827) (← links)
- The Effect of Molecular Diagnostics on the Treatment of Glioma (Q38743781) (← links)
- Glioma Subclassifications and Their Clinical Significance. (Q38747746) (← links)
- Advances in the molecular genetics of gliomas - implications for classification and therapy (Q38777058) (← links)
- Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma. (Q38778367) (← links)
- Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. (Q38781649) (← links)
- Investigational new drugs for brain cancer (Q38832510) (← links)
- Further understanding of the pathology of glioma: implications for the clinic (Q38844945) (← links)
- Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells. (Q38853116) (← links)
- BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities. (Q38919639) (← links)
- New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M. (Q39167472) (← links)
- Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. (Q39208269) (← links)
- Characterization of gliomas: from morphology to molecules (Q39412967) (← links)
- Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. (Q39650208) (← links)
- A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation (Q40896858) (← links)
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers (Q41264935) (← links)
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent. (Q41909818) (← links)
- BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas. (Q42731010) (← links)
- Adult classical glioblastoma with a BRAF V600E mutation (Q43185363) (← links)
- Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. (Q46037449) (← links)
- Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas. (Q46122173) (← links)
- The arc of fellowship (Q46173911) (← links)
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins? (Q46365183) (← links)
- Precision Medicine in Pediatric Neurooncology: A Review. (Q47288778) (← links)
- Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma? (Q47551433) (← links)
- Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. (Q47827207) (← links)
- Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease. (Q48015053) (← links)
- Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib. (Q48122467) (← links)